Skip to main content
Equibles

Joe Schwartz

Analyst

Larynx Partners

Equibles does not estimate personal net worth.

About Joe Schwartz

Joe Schwartz is recorded as Analyst at Larynx Partners. Joe Schwartz has spoken on 2 earnings calls across 2 companies, most recently for Biomarin Pharmaceutical Inc on May 4, 2026. Those appearances were for Biomarin Pharmaceutical Inc (BMRN) and INSMED Inc (INSM). The companies whose calls Joe Schwartz spoke on are classified in the Healthcare sector.

Joe Schwartz on recent calls

“I was wondering if we could get some more perspective on your guidance raise for the enzyme therapies business. We see it increased by $500 million, and we estimate that Amicus generated around $450 million in revenue for Galifold and Palmop in the comparable eight months last year.”
Analyst — Larynx Partners, Biomarin Pharmaceutical Inc Q1 FY2026 Earnings Call ·
“And congrats on the very strong performance. It certainly seems like the TAM for Brinsupri has a lot of room to expand with a very well-designed strategy to identify patients with COPD or asthma who are exacerbating with bronchiectasis.”
Analyst — Larynx Partners, Earnings conference call (announced in 8-K) ·

Affiliation history

  • Larynx Partners

    Analyst

    Transcript header (unverified)

    Current

Company network

Recent activity